Learn Why We Are the Largest and Most Successful Ophthalmology Clinical Trials Site in the US

Patients: Explore clinical trials across nearly every area of eye care. We’ll help you enroll in a trial that could improve your eye health, help others, and compensate you for your time.

Patients – View Open Trials

Partners / Sponsors / CROs: Work with a trusted clinical trial site with 25 FDA approvals and nearly 500 completed sponsored, randomized trials—helping you enroll faster, generate high-quality data, and keep your trial on track.

Partners / Sponsors – Learn More

Located Near Downtown Louisville, KY, in Butchertown

1536 Story Ave
Louisville, KY 40206
Call (502) 219-7700

Office hours:
Mon – Fri: 8 AM – 5 PM EST
Sat – Sun: Closed

FDA Approvals
Clinical Trials
Years of Principal Investigator Experience
Trialed Medical Conditions
bct building

About Butchertown Clinical Trials

Butchertown Clinical Trials is a clinical trials research site in Louisville, KY, specializing in ophthalmic, vaccine, adult medicine, and metabolic disease clinical trials. Our mission is to help improve treatments and access to innovative care for all patients by involving them in clinical trials. We regularly recruit study subjects for paid clinical trials sponsored by pharmaceutical companies and medical equipment firms to prove the usefulness of new treatments, surgical implants, or diagnostic medical devices.

Learn More

How We Do Dry Eye Research and Paid Clinical Trials in Louisville, KY

We regularly recruit patients (study subjects) to enroll in dry eye research trials and paid clinical trials that are sponsored by pharmaceutical companies, surgical and medical equipment firms, and others attempting to prove the usefulness of a new pharmaceutical agent, treatments, surgical implants, or diagnostic medical devices.

How Does It Work?
dry eye research

We are always enrolling for our clinical research trials and studies for:

  • Dry Eye Disease
  • Cataract
  • Macular Degeneration
  • Glaucoma
  • Diabetic Retinopathy
  • Corneal Dystrophy
  • Geographic Atrophy
  • LASIK and post-operative conditions
  • Conjunctivitis
  • Conditions of the Eye and Ocular Adnexa
  • Environmental Allergies
  • Seasonal Allergies
  • Presbyopia
  • Hypertension
  • Hypothyroid
  • High Cholesterol
  • Nutrition and Weight Loss
  • Type I and Type II Diabetes

New Posts From the Blog

Diversity, Equity, and Inclusion at The Eye Care Institute, Butchertown Clinical Trials, and the Diversity of Clinical Trials

We believe the unique talents, qualities, and characteristics of our staff and doctors give us the opportunity to reach our goals of improving vision through our routine, medical and surgical eye care services, and improving human health through the services provided by our clinical trials division. We have many training programs, initiatives, and resources to allow our staff members to…

Butchertown Clinical Trials and The Eye Care Institute Announce Our 15th FDA Approval Vuity™

This is the first and only eye drop approved for daily correction of near and intermediate vision without affecting distance vision and our third approval in 15 days. For Immediate Release Allergan, an AbbVie company, announced the U.S. Food and Drug Administration (FDA) has approved VUITY™ (pilocarpine HCl ophthalmic solution) 1.25% for the treatment of presbyopia, commonly known as age-related…

The Ideal Clinical Trials Research Site

Our Facility Butchertown Clinical Trials is a dedicated clinical research facility on our 21,000 sq. ft. medical campus. It is equipped with the following features and amenities. Read More Our Client’s Success – 12 Approved Drugs Just Announced … Our Clients’ Most Recent Success, 13th and 14th Approved Drugs Who We Are Butchertown Clinical Trials is an Ophthalmic, Vaccine, Adult…

Butchertown Clinical Trials and The Eye Care Institute Announce Our 14th FDA Approval Tyrvaya™

October 19, 2021 For Immediate Release Oyster Point Pharma, a Princeton, NJ company, has announced the FDA has approved Tyrvaya™ as the first and only nasal spray approved for treating signs and symptoms of Dry Eye Disease. Guruprasad R. Pattar, MD, PhD, of The Eye Care Institute and Butchertown Clinical Trials, was a principal investigator for the clinical trials leading…

Butchertown Clinical Trials and The Eye Care Institute Announce Our 13th FDA Approval Dextenza®

October 18, 2021 For Immediate Release Ocular Therapeutix, a Bedford, MA company, has announced the FDA has approved Dextenza® for treating ocular itching associated with allergic conjunctivitis. John C. Meyer, MD, of The Eye Care Institute and Butchertown Clinical Trials, was a principal investigator for the clinical trials leading to the FDA approval of this new treatment option for persons…

Health care research facility opens in Butchertown

The Eye Care Institute opened a new research facility on its Butchertown campus. Butchertown Clinical Trials, a division of the Eye Care Institute, announced Friday that the $1.8 million stand-alone clinical trials facility opened at 205 N. Spring Street. It will house eight ongoing clinical trials, according to a news release. Louisville Business First reported in January 2020 that the Eye Care…

Receive Announcements on Upcoming Research Trials

We regularly recruit patients (study subjects) to enroll in dry eye research trials and paid clinical trials that are sponsored by pharmaceutical companies, surgical and medical equipment firms, and others attempting to prove the usefulness of a new pharmaceutical agent, treatments, surgical implants, or diagnostic medical devices.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Get Started Today

We regularly recruit patients (study subjects) to enroll in clinical trials sponsored by pharmaceutical companies, surgical and medical equipment firms, and others attempting to prove the usefulness of a new pharmaceutical agent, treatments, surgical implants, or diagnostic medical devices. View open trials today.

Contact Us